CTD NeeS & eCTD compilation and submission of the dossiers
- No programming experience needed. You will learn everything in this course.
CTD "Common Technical Documents" is the mandatory format for regulatory submissions worldwide.
This course explains the rationale for the CTD, NeeS & eCTD. Also, provides detailed guidance on its structure and format.
Several MENA authorities had implemented eCTD/NeeS or CTD as a submission format for pharmaceutical products. Almost Global authorities (Ministries of health) have implemented CTD submission as a standard guideline for registration of products.
All pharmaceutical companies are looking for new global markets’ opportunities through exportation of their drug products. As exportation promote the pharmaceutical field and encourage the investments in the pharmaceutical industry. In order to succeed in export, all companies should be familiar with the implementation of the unified global registration system which is called CTD, as well as should know how to prepare their pharmaceutical/biological registration files to be complying to the global unified registration system.
Participants completing this course should be able to:
* Prepare submissions to regulatory authorities in all countries or regions where the CTD/NeeS/eCTD formats are mandatory, recommended or accepted.
* Understand the differences between CTD, NeeS & eCTD.
1. Role of regulatory affairs.
2. Definition and difference between CTD, NeeS & eCTD.
3. CTD/eCTD history.
4. Organization of CTD (Module 1, 2, 3, 4, & 5)
5. Criteria of dossier preparation.
Who this course is for:
- RA " Regulatory Affairs " (Local & Export)
- R&D "Research & Development"
- QC " Quality Control"
- QA "* Quality Assurance "
- SC "Supply Chain"
- Medical Affairs
Asmaa Khalil is manager of Regulatory Affairs at Boston Biopharma. She has more than 15 years’ experience in global regulatory affairs “MENA Region, African Countries, CIS Region, APAC region & EU region”. Asmaa is expert consultant in CTD, NeeS & eCTD compilation and submission/publishing of dossier. She was the speaker of more than 30 workshops in Egypt & GCC for regulatory affairs and CTD/eCTD sessions.
Asmaa earned her B.S. in Pharmaceutical Sciences from Cairo University, and her M Sc. in Biochemistry.